| __timestamp | Ascendis Pharma A/S | Cytokinetics, Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 6274000 | 17268000 |
| Thursday, January 1, 2015 | 9415000 | 19667000 |
| Friday, January 1, 2016 | 11504000 | 27823000 |
| Sunday, January 1, 2017 | 13482000 | 36468000 |
| Monday, January 1, 2018 | 25057000 | 31282000 |
| Tuesday, January 1, 2019 | 48473000 | 39610000 |
| Wednesday, January 1, 2020 | 76669000 | 52820000 |
| Friday, January 1, 2021 | 160180000 | 96803000 |
| Saturday, January 1, 2022 | 221227000 | 177977000 |
| Sunday, January 1, 2023 | 264410000 | 173612000 |
| Monday, January 1, 2024 | 284545000 |
Data in motion
In the competitive world of biotechnology, managing operational expenses is crucial for sustainable growth. Ascendis Pharma A/S and Cytokinetics, Incorporated, two prominent players, have shown distinct trends in their Selling, General, and Administrative (SG&A) expenses over the past decade.
From 2014 to 2023, Ascendis Pharma A/S saw a staggering increase in SG&A expenses, growing by over 4,100%, from approximately $6.3 million to $264 million. This reflects their aggressive expansion strategy and investment in operational capabilities. In contrast, Cytokinetics, Incorporated experienced a more moderate increase of around 900%, with expenses rising from $17 million to $174 million.
This divergence highlights different strategic approaches: Ascendis's rapid scaling versus Cytokinetics's steady growth. Investors and stakeholders should consider these trends when evaluating the companies' long-term potential and operational efficiency.
Comparing SG&A Expenses: Novartis AG vs Cytokinetics, Incorporated Trends and Insights
Breaking Down SG&A Expenses: Viatris Inc. vs Cytokinetics, Incorporated
Summit Therapeutics Inc. vs Cytokinetics, Incorporated: SG&A Expense Trends
Who Optimizes SG&A Costs Better? Dr. Reddy's Laboratories Limited or Ascendis Pharma A/S
Operational Costs Compared: SG&A Analysis of Walgreens Boots Alliance, Inc. and Cytokinetics, Incorporated
Ascendis Pharma A/S or Xenon Pharmaceuticals Inc.: Who Manages SG&A Costs Better?
SG&A Efficiency Analysis: Comparing Ascendis Pharma A/S and PTC Therapeutics, Inc.
Ascendis Pharma A/S or Evotec SE: Who Manages SG&A Costs Better?
Who Optimizes SG&A Costs Better? Cytokinetics, Incorporated or TG Therapeutics, Inc.
Comparing SG&A Expenses: Cytokinetics, Incorporated vs Rhythm Pharmaceuticals, Inc. Trends and Insights
Cytokinetics, Incorporated vs Bausch Health Companies Inc.: SG&A Expense Trends
Comparing SG&A Expenses: Cytokinetics, Incorporated vs Wave Life Sciences Ltd. Trends and Insights